ULTRAVIST 370 iopromide 384.5 g/500 mL solution for injection bottle Австралія - англійська - Department of Health (Therapeutic Goods Administration)

ultravist 370 iopromide 384.5 g/500 ml solution for injection bottle

bayer australia ltd - iopromide, quantity: 768.86 mg/ml - injection, solution - excipient ingredients: dilute hydrochloric acid; sodium calcium edetate; trometamol; water for injections; sodium hydroxide - ultravist is indicated for all angiographic and urographic examinations and for contrast enhancement in computerised tomography.,ultravist 300 or 370 is indicated for use in contrast-enhanced mammography (cem) in adults, to visualise known or suspected lesions of the breast as an adjunct to mammography (with or without ultrasound).

ULTRAVIST-240 iopromide 49.872g/100mL injection bottle Австралія - англійська - Department of Health (Therapeutic Goods Administration)

ultravist-240 iopromide 49.872g/100ml injection bottle

bayer australia ltd - iopromide, quantity: 498.72 mg/ml - injection, solution - excipient ingredients: water for injections; trometamol; sodium calcium edetate; dilute hydrochloric acid; sodium hydroxide - indications: ultravist is indicted for all angiographic and urographic examinations and for contrast enhancements in computerised tomography. ultravist 240 is additionally indicated for lumbar myelography in adults.

ULTRAVIST-240 iopromide 4.9872g/10mL injection    bottle Австралія - англійська - Department of Health (Therapeutic Goods Administration)

ultravist-240 iopromide 4.9872g/10ml injection bottle

bayer australia ltd - iopromide, quantity: 498.72 mg/ml - injection, solution - excipient ingredients: dilute hydrochloric acid; water for injections; trometamol; sodium calcium edetate; sodium hydroxide - indications: ultravist is indicated for all angiographic and urographic examinations and for contrast enhancements in computerised tomography. ultravist 240 is additionally indicated for lumbar myelography in adults.

ULTRAVIST 240 Iopromide 24.936g/50mL injection Австралія - англійська - Department of Health (Therapeutic Goods Administration)

ultravist 240 iopromide 24.936g/50ml injection

bayer australia ltd - iopromide, quantity: 498.72 mg/ml - injection, solution - excipient ingredients: water for injections; trometamol; sodium calcium edetate; dilute hydrochloric acid; sodium hydroxide - all angiographic and urographic examinations and for contrast enhancement in computerized tomography. indications as at 6th july 2001: ultravist is indicated for all angiographic and urographic examinations and for contrast enhancements in computerised tomography. ultravist 240 is additionally indicated for lumbar myelography in adults.

Ultravist 240 Нова Зеландія - англійська - Medsafe (Medicines Safety Authority)

ultravist 240

bayer new zealand limited - iopromide 498.72 mg/ml equivalent to 240 mg iodine - solution for infusion - 240 mg/ml - active: iopromide 498.72 mg/ml equivalent to 240 mg iodine excipient: hydrochloric acid as 10% solution sodium calcium edetate, hydrate trometamol water for injection - for intravascular use and use in body cavities. contrast enhancement in computerised tomography (ct), arteriography and venography, intravenous/intra-arterial digital subtraction angiography (dsa), intravenous urography, use for ercp, arthrography and examination of other body cavities. ultravist 240: also for intrathecal use. ultravist 370: especially for angiocardiography. ultravist 300/370: not for intrathecal use.

Ultravist 300 Нова Зеландія - англійська - Medsafe (Medicines Safety Authority)

ultravist 300

bayer new zealand limited - iopromide 623 mg/ml equivalent to iodine 300 mg/ml - solution for infusion - 300 mg/ml - active: iopromide 623 mg/ml equivalent to iodine 300 mg/ml excipient: hydrochloric acid as 10% solution sodium calcium edetate trometamol water for injection - for intravascular use and use in body cavities. contrast enhancement in computerised tomography (ct), arteriography and venography, intravenous/intra-arterial digital subtraction angiography (dsa), intravenous urography, use for ercp, arthrography and examination of other body cavities. ultravist 240: also for intrathecal use. ultravist 370: especially for angiocardiography. ultravist 300/370: not for intrathecal use.

Ultravist 370 Нова Зеландія - англійська - Medsafe (Medicines Safety Authority)

ultravist 370

bayer new zealand limited - iopromide 769 mg/ml equivalent to iodine 370 mg/ml - solution for infusion - 370 mg/ml - active: iopromide 769 mg/ml equivalent to iodine 370 mg/ml excipient: hydrochloric acid sodium calcium edetate trometamol water for injection - for intravascular use and use in body cavities. contrast enhancement in computerised tomography (ct), arteriography and venography, intravenous/intra-arterial digital subtraction angiography (dsa), intravenous urography, use for ercp, arthrography and examination of other body cavities. ultravist 240: also for intrathecal use. ultravist 370: especially for angiocardiography. ultravist 300/370: not for intrathecal use.

ULTRAVIST 300 Iopromide 93.51g/150mL injection Австралія - англійська - Department of Health (Therapeutic Goods Administration)

ultravist 300 iopromide 93.51g/150ml injection

bayer australia ltd - iopromide, quantity: 623.4 mg/ml - injection - excipient ingredients: trometamol; sodium calcium edetate; water for injections; dilute hydrochloric acid; sodium hydroxide - all angiographic and urographic examinations and for contrast enhancement in computerised tomography.

ULTRAVIST 300 Iopromide 62.34g/100mL injection Австралія - англійська - Department of Health (Therapeutic Goods Administration)

ultravist 300 iopromide 62.34g/100ml injection

bayer australia ltd - iopromide, quantity: 623.4 mg/ml - injection - excipient ingredients: trometamol; dilute hydrochloric acid; water for injections; sodium calcium edetate; sodium hydroxide - all angiographic and urographic examinations and for contrast enhancement in computerised tomography.